| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K80183349 |
| PharmacoGx | BRD-K80183349 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TOR3A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | BCOR | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | KANSL1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | RPRD2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | ERMN | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | TADA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
